Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Handbook of Experimental Pharmacology
|
November 27, 2019
Quality in Non-GxP Research Environment
Sandrine Bongiovanni, Robert Purdue, Oleg Kornienko, et al.
Assay and Drug Development Technologies
|
July 13, 2006
Development of the high throughput screening assay for identification of agonists of an orphan nuclear receptor
Marianna Kapitskaya, Michael E Cunningham, Raul Lacson, et al.
Assay and Drug Development Technologies
|
March 16, 2007
Ultra-high-throughput screening for antagonists of a Gi-coupled receptor in a 2.2-microl 3,456-well plate format cyclicAMP assay
Michael Weber, Lalitha Muthusubramaniam, Justin Murray, et al.
Assay and Drug Development Technologies
|
September 5, 2007
Miniaturization and automation of an ubiquitin ligase cascade enzyme-linked immunosorbent assay in 1,536-well format
Jason Cassaday, Tarak Shah, Justin Murray, et al.
Journal of Biomolecular Screening
|
May 14, 2004
Miniaturization of whole live cell-based GPCR assays using microdispensing and detection systems
Oleg Kornienko, Raul Lacson, Priya Kunapuli, et al.
Analytical Biochemistry
|
March 3, 2006
Identification of small molecule antagonists of the human mas-related gene-X1 receptor
Priya Kunapuli, Seungtaek Lee, Wei Zheng, et al.
Journal of Biomolecular Screening
|
June 9, 2006
A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase
Philip E Brandish, Chi-Sung Chiu, Jonathan Schneeweis, et al.
Analytical Biochemistry
|
June 27, 2006
A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation
Shane Marine, Elize Zamiara, S Todd Smith, et al.
Assay and Drug Development Technologies
|
May 3, 2008
A fluorescence-based thiol quantification assay for ultra-high-throughput screening for inhibitors of coenzyme A production
Christine C Chung, Kenji Ohwaki, Jonathan E Schneeweis, et al.
Assay and Drug Development Technologies
|
April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format
Norbert T Peekhaus, Marc Ferrer, Tina Chang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Handbook of Experimental Pharmacology
|
November 27, 2019
Quality in Non-GxP Research Environment
Sandrine Bongiovanni, Robert Purdue, Oleg Kornienko, et al.
Assay and Drug Development Technologies
|
July 13, 2006
Development of the high throughput screening assay for identification of agonists of an orphan nuclear receptor
Marianna Kapitskaya, Michael E Cunningham, Raul Lacson, et al.
Assay and Drug Development Technologies
|
March 16, 2007
Ultra-high-throughput screening for antagonists of a Gi-coupled receptor in a 2.2-microl 3,456-well plate format cyclicAMP assay
Michael Weber, Lalitha Muthusubramaniam, Justin Murray, et al.
Assay and Drug Development Technologies
|
September 5, 2007
Miniaturization and automation of an ubiquitin ligase cascade enzyme-linked immunosorbent assay in 1,536-well format
Jason Cassaday, Tarak Shah, Justin Murray, et al.
Journal of Biomolecular Screening
|
May 14, 2004
Miniaturization of whole live cell-based GPCR assays using microdispensing and detection systems
Oleg Kornienko, Raul Lacson, Priya Kunapuli, et al.
Analytical Biochemistry
|
March 3, 2006
Identification of small molecule antagonists of the human mas-related gene-X1 receptor
Priya Kunapuli, Seungtaek Lee, Wei Zheng, et al.
Journal of Biomolecular Screening
|
June 9, 2006
A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase
Philip E Brandish, Chi-Sung Chiu, Jonathan Schneeweis, et al.
Analytical Biochemistry
|
June 27, 2006
A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation
Shane Marine, Elize Zamiara, S Todd Smith, et al.
Assay and Drug Development Technologies
|
May 3, 2008
A fluorescence-based thiol quantification assay for ultra-high-throughput screening for inhibitors of coenzyme A production
Christine C Chung, Kenji Ohwaki, Jonathan E Schneeweis, et al.
Assay and Drug Development Technologies
|
April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format
Norbert T Peekhaus, Marc Ferrer, Tina Chang, et al.
Page
of 1